Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Plasminogen

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Soleo Health partners for RYPLAZIM® treatment.
    Soleo Health partners for RYPLAZIM® treatment.

    06 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240506793284/en

    BUSINESSWIRE
    06 May 2024
    Share Share
    Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US
    Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US

    29 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kedrion-announces-rare-disease-medicine-ryplazim-now-available-in-us-302130342.html

    PR NEWSWIRE
    29 Apr 2024
    Share Share
    Liminal BioSciences Announces Upcoming Presentations for Ryplazim®
    Liminal BioSciences Announces Upcoming Presentations for Ryplazim®

    04 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/liminal-biosciences-announces-upcoming-presentations-for-ryplazim-plasminogen-at-the-62nd-ash-annual-meeting-and-exposition-301166982.html

    PRNEWSWIRE
    04 Nov 2020
    Share Share
    Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®
    Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®

    21 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/liminal-biosciences-provides-update-on-progress-on-bla-for-ryplazimplasminogen-301134619.html

    PRNEWSWIRE
    21 Sep 2020
    Share Share
    Liminal resubmits Biologics License Application to U.S. FDA for Ryplazim
    Liminal resubmits Biologics License Application to U.S. FDA for Ryplazim

    08 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/liminal-biosciences-announces-resubmission-of-biologics-license-application-to-us-food-and-drug-administration-for-ryplazim-plasminogen-for-treatment-of-congenital-plasminogen-deficiency-301125349.html

    PRNEWSWIRE
    08 Sep 2020
    Share Share
    Prometic presents new PBI-4050 and Ryplazim™ (plasminogen) data on lung fibrosis
    Prometic presents new PBI-4050 and Ryplazim™ (plasminogen) data on lung fibrosis

    22 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prometic-presents-new-pbi-4050-and-ryplazim-plasminogen-data-on-lung-fibrosis-at-the-2019-ats-conference-300855067.html

    PR NEWSWIRE
    22 May 2019
    Share Share